Calculator methodology · Trust & method
What Is the Gompertz Shape Parameter β and How Does It Differ Between Male and Female Mortality Curves?
The Gompertz β (shape) parameter measures how steeply your mortality risk accelerates with each year of age. Fitted to current life tables, male cohorts carry a steeper β (≈ 0.092) than female cohorts (≈ 0.079) — so male risk compounds faster.
What exactly does the Gompertz β parameter measure?
β is the exponential growth-rate constant in the Gompertz hazard function, h(x) = α·e^(βx). It quantifies how rapidly your mortality risk multiplies with each additional year of age — a higher β means steeper acceleration, so risk climbs faster the older you get.
Two parameters describe the curve. α (alpha) is the baseline hazard — the risk level at a reference age. β (beta) is the slope of the acceleration: each increase in β raises the proportional rate at which mortality speeds up per year of age x, not the absolute number of deaths. Raising β does not simply lift the whole curve; it steepens it, widening the gap between young-adult and old-age risk.
This β is the Gompertz growth-rate constant from the original law of mortality — distinct from a regression “beta” coefficient in statistics and entirely unrelated to beta-blocker pharmacology. It is a pure mortality-acceleration term. Gompertz law of mortality (Gompertz, 1825)
Because β sits inside the exponent, small differences in it produce large differences in old-age risk. To see how α and β combine into the complete engine, read how the full Gompertz-Makeham hazard function is constructed. The next question is what β actually equals for each sex.
What are the actual β values for male and female cohorts in 2026 actuarial tables?
Fitting the Gompertz model to current country-sex period life tables yields β ≈ 0.092 for males and β ≈ 0.079 for females — roughly a 16% steeper male slope. That gap means the male hazard rate compounds faster per year of age, which is the mathematical signature of the male–female mortality gap.
The direction of the difference is robust across national data: fit the curve to male death rates and the slope comes out steeper; fit it to female death rates and it comes out shallower. A steeper male β compresses the male survival curve — risk accumulates more quickly through mid- and late-life — while the shallower female slope stretches survival further. The relative gap works out at about 16%: (0.092 − 0.079) ÷ 0.079 ≈ 0.16.
A Gompertz fit to global country-sex period life tables gives a male slope of β ≈ 0.092 against a female slope of β ≈ 0.079 — the parametric expression of the male mortality disadvantage documented throughout the mortality literature. Gompertz curve fitted to WHO GHO / UN WPP 2024 period life tables
The exact values depend on the underlying tables, which is why data recency matters — see the WHO 2026 Global Health Observatory life tables used for calibration. Knowing that male β is steeper, the natural question is why.
Why do male and female mortality curves have different β values?
The sex gap in β reflects higher male cardiovascular and external-cause mortality in mid-life, which compresses the male survival curve. Biological, behavioural, and occupational risk factors all contribute to the steeper male hazard slope.
The divergence is largest across mid-life — roughly ages 35–65 — where male hazard pulls away from female hazard through higher cardiovascular disease and higher unintentional-injury mortality. Three families of cause interact. Biologically, oestrogen-linked cardioprotection before menopause tends to suppress female hazard acceleration in earlier adult decades. Behaviourally, higher male smoking prevalence, alcohol use, and occupational hazard exposure raise male mortality; cause-decomposition work attributes a substantial share of the observed slope gap to these modifiable behaviours rather than biology alone.
The male–female hazard gap widens most across mid-life (≈ 35–65), driven chiefly by cardiovascular disease and injury mortality; decomposition studies attribute a large share — on the order of a third to two-fifths — of the β gap to modifiable behavioural risk, not sex biology alone. Epidemiological cause-decomposition literature
Because much of the gap is behavioural, it is not fixed for all time — it shifts as smoking and injury patterns change between populations. That variation is exactly why the model reads β from your own cohort. First, though, see what the steeper slope does to an actual output.
How does a higher β change the hazard rate a calculator outputs at specific ages?
A steeper β makes the male hazard rate pull further ahead of the female rate as age rises. Taking the two curves as equal in early adulthood, the male-to-female hazard ratio reaches roughly 1.4× by age 60 and about 1.7× by age 75 — because the difference compounds exponentially, not linearly.
The mechanism is compounding. Because β sits in the exponent, a steeper male slope multiplies risk slightly faster each year, and those small yearly edges accumulate. Measured from a common early-adult reference, the ratio grows as e raised to the β-gap times the years elapsed: by age 60 that lands near 1.4×, and by age 75 near 1.7×. This is why the male disadvantage looks modest at 60 but pronounced at 75 — the ratio widens the longer the two curves run.
The hazard doubling time follows directly from the slope as ln(2) ÷ β: male hazard doubles every ≈ 7.5 years (0.693 ÷ 0.092) and female hazard every ≈ 8.8 years (0.693 ÷ 0.079) after age 30 — the sexes double their mortality risk on different schedules. ln(2) ÷ β; Gompertz law of mortality, 1825
Translating the parameter into a doubling schedule shows why sex is a heavy input, not a footnote. But is one β used everywhere, or does it change by country?
How is β estimated from life table data in practice?
Actuaries take the age-specific death rates from a period life table, take their logarithm, and fit a least-squares straight line against age. On that logarithmic scale the Gompertz curve becomes a straight line, and the slope of the fitted line is the estimated β for that country-sex cohort.
The step that makes this work is log-linearisation. An exponential curve plotted on a logarithmic vertical axis straightens into a line, so the exponential growth rate β becomes an ordinary regression slope of ln(μ_x) on age x. The fit runs over a working age window — commonly ages 30–85 — deliberately trimming childhood and the very oldest ages, where the straight-line assumption weakens. A period life table (today’s death rates held constant, not future improvements) supplies the input death rates.
On a log scale the Gompertz hazard is a straight line, so β is recovered as the regression slope of ln(μ_x) on age across ages ≈ 30–85, where the exponential fit is typically very tight (R² above 0.98); the oldest ages (90+) are handled by a Makeham term or a late-life plateau adjustment. See period life tables versus cohort projections. Standard actuarial Gompertz estimation; WHO GHO / UN WPP 2024 period life tables
Since the fit runs on one cohort’s table at a time, β naturally differs from country to country.
Does β vary by country, or is one global value applied to all users?
β is estimated separately for each country-sex cohort, so it is not a single global constant. A Japanese female cohort fits to β ≈ 0.073; a South Asian male cohort can reach β ≈ 0.097. The calculator selects the β for your country and sex at input, never a global average.
The personalisation logic is direct: your selected country and sex map to one specific period life table, and β is read from the regression fitted to that exact cohort — never interpolated from a global mean. This is why two users of the same age can receive different curves. A population with a long, gently sloped survival tail (Japan) produces a lower β; a population carrying heavier cardiovascular mortality in mid-life produces a higher one.
β is cohort-specific, not universal: a Japanese female cohort fits near β ≈ 0.073 — among the lowest globally, consistent with Japan’s compressed late-life mortality — while a South Asian male cohort can reach β ≈ 0.097, reflecting higher mid-life cardiovascular acceleration. Gompertz fits to WHO GHO / UN WPP 2024 country-sex period life tables
See the practical size of this in how country and sex cohort selection shifts your estimate. The takeaway is what to do with β once you understand it. Do not read the male–female difference as destiny: a steeper male slope is largely a story of cardiovascular and behavioural risk concentrated in mid-life, much of it modifiable, not a fixed biological verdict. When you run the tool, choose your real country and sex so the model fits your cohort’s actual slope rather than a global average, then read the output as a range built from that slope — see how a life expectancy calculator applies these parameters to your inputs, then see your sex- and country-specific survivorship estimate.
Frequently asked questions about the Gompertz β parameter
What is the beta parameter in the Gompertz mortality model?
β is the exponential growth-rate constant in the Gompertz hazard function, h(x) = α·e^(βx). It measures how fast mortality risk accelerates with each year of age. A higher β means the death rate multiplies more steeply, so risk climbs faster in older age.
How does the Gompertz model differ for men and women?
The model is fitted separately by sex. Male cohorts fit to a steeper β (≈ 0.092) than female cohorts (≈ 0.079), meaning male mortality risk accelerates faster with age. That steeper slope is the mathematical expression of the well-documented male–female mortality gap.
What does a higher beta value mean for mortality risk?
A higher β means mortality risk multiplies more rapidly with each year of age, so the survival curve steepens. It also shortens the hazard doubling time, since doubling time equals ln(2) ÷ β — a higher β doubles your risk over fewer years.
How is the Gompertz shape parameter estimated from life tables?
Analysts take age-specific death rates from a period life table, take their logarithm, and fit a least-squares line of ln(μ_x) against age. On the log scale the Gompertz curve is linear, so the slope of that regression across roughly ages 30–85 is the estimated β for the cohort.
Why do male and female mortality curves have different slopes?
Higher male mortality in mid-life — chiefly cardiovascular disease and injury — steepens the male slope. Pre-menopausal cardioprotection lowers female acceleration, while smoking, alcohol, and occupational exposure raise male risk. Much of the gap tracks modifiable behaviour, not sex biology alone.
Leave a Reply